
Cellarity closes $121M financing, uses single-cell technologies to identify cellular drivers during the transition from health to disease
Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are…
Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are…
New technology enables highest levels of accuracy at immense scale, with the power to sequence…
Element Biosciences, developer of an innovative DNA sequencing platform set to disrupt the genomics industry…
Exai Bio, a next-generation liquid biopsy company, and researchers at UCSF are presenting data from…
Lexogen, a transcriptomics and Next-Generation Sequencing company announced the release of the new RiboCop rRNA…
High-throughput sequencing methods mainly based on Illumina platforms have benefited the entire field of biology…
Expression levels of pathological dysregulated neurodegenerative genes of both Alzheimer’s and Parkinson’s disease were significantly…
Veracyte today announced that new clinical validation data published online in Thyroid show that the company’s RNA…
IgGenix, a biotechnology company taking a revolutionary approach to directly alleviate allergic disease, today announced…
Aspen Neuroscience, Inc. Director of Bioinformatics, Roy Williams, Ph.D., presented NeuriTest for the first time publicly last…